Modes of Delivery of Genetic Testing Services and the Uptake of Cancer Risk Management Strategies in BRCA1 and BRCA2 Carriers.

Pal T, Lee JH, Besharat A, Thompson Z, Monteiro AN, Phelan C, Lancaster JM, Metcalfe K, Sellers TA, Vadaparampil S, Narod SA.

Source

H. Lee Moffitt Cancer Center, Tampa, FL.

Abstract

BRCA testing services are now offered by various healthcare providers, thus it is important to evaluate whether the implementation of cancer risk management (CRM) strategies varies by service provider. Using a registry-based sample of 795 female BRCA mutation carriers, we explored the association between uptake of CRM strategies with duration of genetic counseling (GC) sessions, provider type, and other demographic and clinical variables. All participants completed a baseline questionnaire. Information about uptake of CRM strategies was collected for a subset of 438 participants who completed additional questions. Summary statistics and Pearson Chi square tests were used to examine the associations between demographic and clinical variables with service delivery factors and with the uptake of various CRM strategies. Overall uptake of CRM strategies was high across all provider types. However, GC sessions were longer when provided by a genetics professional than by another provider (p<0 .001="" a="" and="" associated="" brca="" carriers.="" crm="" delivery="" done="" factors="" frequencies="" furthermore="" gc="" genetics="" higher="" identification="" implementation="" important="" in="" involvement="" is="" longer="" maximize="" most="" of="" optimize="" p="" professional.="" services="" sessions="" specialized="" strategies="" testing="" these="" to="" uptake="" was="" were="" when="" with="">© 2013 John Wiley & Sons A/S.